Literature DB >> 7931822

Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection.

H A Lambkin1, C M Mothersill, P Kelehan.   

Abstract

Immunocytochemical detection of p53 protein products in paraffin sections is possible with a number of antisera, monoclonal and polyclonal. Few corroborative results amongst different laboratories have been published due to variations in the antibodies, the fixation protocols, and the immunocytochemical methods applied. Antigen unmasking methods employing microwaves or proteolytic enzymes add to the disparity in the percentage of positive cases reported. In this study, paraffin sections of 55 cases of cervical carcinoma were immunostained with monoclonal antibodies p53-DO7 and p53-1801 (a) without section pretreatment, (b) with pronase digestion, and (c) with microwave antigen retrieval in citric acid buffer. Specimens fixed in buffered formalin required antigen unmasking to show positive staining. Pronase digestion caused false-negative immunostaining. Microwave pretreatment with p53-DO7 yielded 100 per cent positivity for p53 proteins but only 7/55 cases with more than 50 per cent positive cells. Monoclonal antibody p53-DO7 detected more positive cases than p53-1801. Immunostaining with antibodies to p53 proteins must be interpreted cautiously as variations in fixation, antibodies, and section pretreatment will significantly affect results.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931822     DOI: 10.1002/path.1711720105

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies.

Authors:  P Würl; H Taubert; A Meye; D Berger; C Lautenschläger; H J Holzhausen; H Schmidt; H Kalthoff; F W Rath; H Dralle
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Immunohistochemical analysis of p53 protein in transplant recipients with Kaposi's sarcoma.

Authors:  G Flamini; S Magalini; G Curigliano; G Nanni; A Boninsegna; S Agnes; D Faticato; M Castagneto; A Cittadini
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 3.  Molecular genetic analysis in the pathologic evaluation of solid tumors: theory and practice.

Authors:  D W Visscher; F H Sarkar; J D Crissman
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

4.  Keratin antigen retrieval in oral mucosal biopsies using microwave processing.

Authors:  G R Ogden; D Lunny; E B Lane
Journal:  Histochem J       Date:  1996-12

5.  p53 Overexpression in laryngeal squamous cell carcinoma and dysplasia.

Authors:  C Barbatis; L Loukas; M Grigoriou; I Nikolaou; A Tsikou-Papafragou; N Marsan; K C Gatter; L Kaklamanis
Journal:  Clin Mol Pathol       Date:  1995-08

6.  Prognostic markers for colorectal cancer: expression of P53 and BCL2.

Authors:  H Pereira; S Silva; R Julião; P Garcia; F Perpétua
Journal:  World J Surg       Date:  1997-02       Impact factor: 3.352

7.  p53 immunohistochemical expression of Egyptian cervical carcinoma.

Authors:  H Abd El All; A Rye; P Duvillard
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

8.  Histochemical, clinical, and in vitro beta cell responses in a neonate with persistent hyperinsulinaemic hypoglycaemia of infancy.

Authors:  N S Panesar; C W Poon; C T Liew; G W Wong; N M Hjelm
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

9.  Prognostic value of p53 in breast invasive ductal carcinoma: an immunohistochemical study on 942 cases.

Authors:  G MacGrogan; F Bonichon; I de Mascarel; M Trojani; M Durand; A Avril; J M Coindre
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

10.  Chronology of p53 protein accumulation in gastric carcinogenesis.

Authors:  M E Craanen; P Blok; W Dekker; G J Offerhaus; G N Tytgat
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.